Dorzolamide Hydrochloride And Timolol Maleate Solution/ Drops
Product Images NDC 68083-490

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride And Timolol Maleate (NDC 68083-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide-timolol-spl-dorzolamide-structure (Dorzolamide Timolol Spl Dorzolamide Structure)

Chemical structure of Dorzolamide Hydrochloride, an active ingredient in Dorzolamide Hydrochloride and Timolol Maleate ophthalmic solution.*

FDA Label Image

Dorzolamide-timolol-spl-timolol-structure (Dorzolamide Timolol Spl Timolol Structure)

Chemical structure diagram of the active ingredients Dorzolamide Hydrochloride and Timolol Maleate, as indicated in the product data. The image shows molecular components and bonds of the compounds used in the ophthalmic solution.*

FDA Label Image

Dorzolamide-timolol-spl-figure-a (Dorzolamide Timolol Spl Figure A)

An instructional diagram depicting an ophthalmic solution bottle with labeled components: cap, tamper evident ring, and bottle. The image is related to Dorzolamide Hydrochloride and Timolol Maleate ophthalmic solution.*

FDA Label Image

Dorzolamide-timolol-spl-figure-b (Dorzolamide Timolol Spl Figure B)

An instructional illustration showing how to attach or remove the cap of an ophthalmic solution bottle, featuring a bottle with threaded neck and a cap with a pointed tip. The image includes an arrow indicating a twisting motion to secure or open the cap, labeled as Figure B.*

FDA Label Image

Dorzolamide-timolol-spl-figure-c (Dorzolamide Timolol Spl Figure C)

Illustration showing a hand administering eye drops to the lower eyelid of an eye. The figure is labeled as Figure C, demonstrating the proper technique for ophthalmic solution application.*

FDA Label Image

Dorzolamide-timolol-spl-figure-d (Dorzolamide Timolol Spl Figure D)

An instructional diagram showing how to apply ophthalmic solution drops into the eye. The image depicts a hand holding a dropper bottle above an eye, with a drop about to fall into the eye, demonstrating proper drop instillation technique.*

FDA Label Image

Dorzolamide-timolol-spl-container-label (Dorzolamide Timolol Spl Container Label)

Label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, containing 2% dorzolamide hydrochloride (22.3 mg/mL) and 0.5% timolol maleate (6.8 mg/mL). The solution is for topical eye application and comes in a 10 mL container. Manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions advise keeping at 20°C to 25°C and protecting from light. The label includes a barcode, lot number, and expiration date fields.*

FDA Label Image

Dorzolamide-timolol-spl-container-carton (Dorzolamide Timolol Spl Container Carton)

Packaging label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, USP, by Gland Pharma Limited. The label shows the drug name with strengths 2% / 0.5%, indicating dorzolamide 22.3 mg/mL and timolol maleate 6.8 mg/mL in a 10 mL ophthalmic solution. It includes storage instructions, manufacturing details, an image of an eye, and a barcode. The label also notes Rx only and sterile product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.